The National Comprehensive Cancer Network (NCCN) held a policy summit in Washington, DC on September 9th to explore the role of AI in cancer treatment, both now and in the future.
Participants, including patients and patient advocates, clinicians and policy makers, discussed the new successes of AI in improving oncology medicine and the potential concerns.
Topics raised included issues of implementation and integration on various platforms, surveillance (both internal and government), avoiding disparities, and increasing access to AI-based software.
Collaboration between healthcare and technology organizations in the creation and implementation of AI tools for oncology has also been highlighted, highlighting the observation that many of the challenges facing AI software are also faced in other areas of using AI applications.
The speed at which AI models are evolving has been a common theme for panelists, and some have compared the potential for advances in care that represent key technological changes, such as the transition to electronic medical records.
AI and cancer care were also the topic of the plenary session during the NCCN 2025 Annual Meeting. Sessions can be viewed on the NCCN Continuing Education Portal.
NCCN hosts a Patient Advocacy Summit December 9th, on the cancer treatment needs of veterans and first responders.
